|
1
|
O'Brien TP, Yang GP, Sanders L and Lau LF:
Expression of cyr61, a growth factor-inducible immediate-early
gene. Mol Cell Biol. 10:3569–3577. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bradham DM, Igarashi A, Potter RL and
Grotendorst GR: Connective tissue growth factor: A cysteine-rich
mitogen secreted by human vascular endothelial cells is related to
the SRC-induced immediate early gene product CEF-10. J Cell Biol.
114:1285–1294. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Joliot V, Martinerie C, Dambrine G,
Plassiart G, Brisac M, Crochet J and Perbal B: Proviral
rearrangements and overexpression of a new cellular gene (nov) in
myeloblastosis-associated virus type 1-induced nephroblastomas. Mol
Cell Biol. 12:10–21. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pennica D, Swanson TA, Welsh JW, Roy MA,
Lawrence DA, Lee J, Brush J, Taneyhill LA, Deuel B, Lew M, et al:
WISP genes are members of the connective tissue growth factor
family that are up-regulated in wnt-1-transformed cells and
aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA.
95:14717–14722. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Desnoyers L: Structural basis and
therapeutic implication of the interaction of CCN proteins with
glycoconjugates. Curr Pharm Des. 10:3913–3928. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zuo GW, Kohls CD, He BC, Chen L, Zhang W,
Shi Q, Zhang BQ, Kang Q, Luo J, Luo X, et al: The CCN proteins:
Important signaling mediators in stem cell differentiation and
tumorigenesis. Histol Histopathol. 25:795–806. 2010.PubMed/NCBI
|
|
7
|
Holbourn KP, Acharya KR and Perbal B: The
CCN family of proteins: Structure-function relationships. Trends
Biochem Sci. 33:461–473. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen CC and Lau LF: Functions and
mechanisms of action of CCN matricellular proteins. Int J Biochem
Cell Biol. 41:771–783. 2009. View Article : Google Scholar :
|
|
9
|
Hirschfeld M, zur Hausen A, Bettendorf H,
Jäger M and Stickeler E: Alternative splicing of Cyr61 is regulated
by hypoxia and significantly changed in breast cancer. Cancer Res.
69:2082–2090. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ball DK, Surveyor GA, Diehl JR, Steffen
CL, Uzumcu M, Mirando MA and Brigstock DR: Characterization of 16-
to 20-kilodalton (kDa) connective tissue growth factors (CTGFs) and
demonstration of proteolytic activity for 38-kDa CTGF in pig
uterine luminal flushings. Biol Reprod. 59:828–835. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sha W and Leask A: CCN2 expression and
localization in melanoma cells. J Cell Commun Signal. 5:219–226.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Perbal B: CCN proteins: A centralized
communication network. J Cell Commun Signal. 7:169–177. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Joliot A, Triller A, Volovitch M and
Prochiantz A: Are embryonic forms of NCAM homeobox receptors? C R
Acad Sci III. (Suppl 9): 59–63. 1992.In French.
|
|
14
|
Kyurkchiev S, Yeger H, Bleau AM and Perbal
B: Potential cellular conformations of the CCN3(NOV) protein. Cell
Commun Signal. 2(9)2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Davies SR, Davies ML, Sanders A, Parr C,
Torkington J and Jiang WG: Differential expression of the CCN
family member WISP-1, WISP-2 and WISP-3 in human colorectal cancer
and the prognostic implications. Int J Oncol. 36:1129–1136.
2010.PubMed/NCBI
|
|
16
|
Wiesman KC, Wei L, Baughman C, Russo J,
Gray MR and Castellot JJ: CCN5, a secreted protein, localizes to
the nucleus. J Cell Commun Signal. 4:91–98. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takada Y, Ye X and Simon S: The integrins.
Genome Biol. 8(215)2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang GP and Lau LF: Cyr61, product of a
growth factor-inducible immediate early gene, is associated with
the extracellular matrix and the cell surface. Cell Growth Differ.
2:351–357. 1991.PubMed/NCBI
|
|
19
|
Chen CC, Young JL, Monzon RI, Chen N,
Todorović V and Lau LF: Cytotoxicity of TNFalpha is regulated by
integrin-mediated matrix signaling. EMBO J. 26:1257–1267. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Holbourn KP, Perbal B and Ravi Acharya K:
Proteins on the catwalk: Modelling the structural domains of the
CCN family of proteins. J Cell Commun Signal. 3:25–41. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Segarini PR, Nesbitt JE, Li D, Hays LG,
Yates JR III and Carmichael DF: The low density lipoprotein
receptor-related protein/alpha2-macroglobulin receptor is a
receptor for connective tissue growth factor. J Biol Chem.
276:40659–40667. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao R and Brigstock DR: Low density
lipoprotein receptor-related protein (LRP) is a heparin-dependent
adhesion receptor for connective tissue growth factor (CTGF) in rat
activated hepatic stellate cells. Hepatol Res. 27:214–220. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mercurio S, Latinkic B, Itasaki N,
Krumlauf R and Smith JC: Connective-tissue growth factor modulates
WNT signalling and interacts with the WNT receptor complex.
Development. 131:2137–2147. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nishida T, Kubota S, Fukunaga T, Kondo S,
Yosimichi G, Nakanishi T, Takano-Yamamoto T and Takigawa M:
CTGF/Hcs24, hypertrophic chondrocyte-specific gene product,
interacts with perlecan in regulating the proliferation and
differentiation of chondrocytes. J Cell Physiol. 196:265–275. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Abraham S, Riggs MJ, Nelson K, Lee V and
Rao RR: Characterization of human fibroblast-derived extracellular
matrix components for human pluripotent stem cell propagation. Acta
Biomater. 6:4622–4633. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu H and Rohan T: Role of the insulin-like
growth factor family in cancer development and progression. J Natl
Cancer Inst. 92:1472–1489. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hwa V, Oh Y and Rosenfeld RG: The
insulin-like growth factor-binding protein (IGFBP) superfamily.
Endocr Rev. 20:761–787. 1999.PubMed/NCBI
|
|
28
|
Tomita N, Hattori T, Itoh S, Aoyama E, Yao
M, Yamashiro T and Takigawa M: Cartilage-specific over-expression
of CCN family member 2/connective tissue growth factor (CCN2/CTGF)
stimulates insulin-like growth factor expression and bone growth.
PLoS One. 8:e592262013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kleer CG, Zhang Y, Pan Q and Merajver SD:
WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates
IGF signaling in inflammatory breast cancer. Neoplasia. 6:179–185.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang Y, Pan Q, Zhong H, Merajver SD and
Kleer CG: Inhibition of CCN6 (WISP3) expression promotes neoplastic
progression and enhances the effects of insulin-like growth
factor-1 on breast epithelial cells. Breast Cancer Res.
7:R1080–R1089. 2005. View Article : Google Scholar
|
|
31
|
Abreu JG, Ketpura NI, Reversade B and De
Robertis EM: Connective-tissue growth factor (CTGF) modulates cell
signalling by BMP and TGF-beta. Nat Cell Biol. 4:599–604.
2002.PubMed/NCBI
|
|
32
|
Inoki I, Shiomi T, Hashimoto G, Enomoto H,
Nakamura H, Makino K, Ikeda E, Takata S, Kobayashi K and Okada Y:
Connective tissue growth factor binds vascular endothelial growth
factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J.
16:219–221. 2002.
|
|
33
|
Sakamoto K, Yamaguchi S, Ando R, Miyawaki
A, Kabasawa Y, Takagi M, Li CL, Perbal B and Katsube K: The
nephro-blastoma overexpressed gene (NOV/ccn3) protein associates
with Notch1 extracellular domain and inhibits myoblast
differentiation via Notch signaling pathway. J Biol Chem.
277:29399–29405. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Perbal B, Martinerie C, Sainson R, Werner
M, He B and Roizman B: The C-terminal domain of the regulatory
protein NOVH is sufficient to promote interaction with fibulin 1C:
A clue for a role of NOVH in cell-adhesion signaling. Proc Natl
Acad Sci USA. 96:869–874. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li CL, Martinez V, He B, Lombet A and
Perbal B: A role for CCN3 (NOV) in calcium signalling. Mol Pathol.
55:250–261. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Perbal B: NOV (nephroblastoma
overexpressed) and the CCN family of genes: Structural and
functional issues. Mol Pathol. 54:57–79. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Moritani NH, Kubota S, Sugahara T and
Takigawa M: Comparable response of ccn1 with ccn2 genes upon
arthritis: An in vitro evaluation with a human chondrocytic cell
line stimulated by a set of cytokines. Cell Commun Signal.
3(6)2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kok SH, Hou KL, Hong CY, Wang JS, Liang
PC, Chang CC, Hsiao M, Yang H, Lai EH and Lin SK: Simvastatin
inhibits cytokine-stimulated Cyr61 expression in osteoblastic
cells: A therapeutic benefit for arthritis. Arthritis Rheum.
63:1010–1020. 2011. View Article : Google Scholar
|
|
39
|
Nozawa K, Fujishiro M, Kawasaki M, Kaneko
H, Iwabuchi K, Yanagida M, Suzuki F, Miyazawa K, Takasaki Y, Ogawa
H, et al: Connective tissue growth factor promotes articular damage
by increased osteoclastogenesis in patients with rheumatoid
arthritis. Arthritis Res Ther. 11:R1742009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kular L, Pakradouni J, Kitabgi P, Laurent
M and Martinerie C: The CCN family: A new class of inflammation
modulators? Biochimie. 93:377–388. 2011. View Article : Google Scholar
|
|
41
|
Parisi MS, Gazzerro E, Rydziel S and
Canalis E: Expression and regulation of CCN genes in murine
osteoblasts. Bone. 38:671–677. 2006. View Article : Google Scholar
|
|
42
|
Luo X, Ding L and Chegini N: CCNs,
fibulin-1C and S100A4 expression in leiomyoma and myometrium:
Inverse association with TGF-beta and regulation by TGF-beta in
leiomyoma and myometrial smooth muscle cells. Mol Hum Reprod.
12:245–256. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mason RM: Connective tissue growth
factor(CCN2), a pathogenic factor in diabetic nephropathy. What
does it do? How does it do it? J Cell Commun Signal. 3:95–104.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Si W, Kang Q, Luu HH, Park JK, Luo Q, Song
WX, Jiang W, Luo X, Li X, Yin H, et al: CCN1/Cyr61 is regulated by
the canonical Wnt signal and plays an important role in
Wnt3A-induced osteoblast differentiation of mesenchymal stem cells.
Mol Cell Biol. 26:2955–2964. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Latinkic BV, Mercurio S, Bennett B, Hirst
EM, Xu Q, Lau LF, Mohun TJ and Smith JC: Xenopus Cyr61 regulates
gastrulation movements and modulates Wnt signalling. Development.
130:2429–2441. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Deng YZ, Chen PP, Wang Y, Yin D, Koeffler
HP, Li B, Tong XJ and Xie D: Connective tissue growth factor is
overexpressed in esophageal squamous cell carcinoma and promotes
tumorigenicity through beta-catenin-T-cell factor/Lef signaling. J
Biol Chem. 282:36571–36581. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Smerdel-Ramoya A, Zanotti S, Deregowski V
and Canalis E: Connective tissue growth factor enhances
osteoblastogenesis in vitro. J Biol Chem. 283:22690–22699. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Rydziel S, Stadmeyer L, Zanotti S, Durant
D, Smerdel-Ramoya A and Canalis E: Nephroblastoma overexpressed
(Nov) inhibits osteoblastogenesis and causes osteopenia. J Biol
Chem. 282:19762–19772. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yosimichi G, Nakanishi T, Nishida T,
Hattori T, Takano-Yamamoto T and Takigawa M: CTGF/Hcs24 induces
chondrocyte differentiation through a p38 mitogen-activated protein
kinase (p38MAPK), and proliferation through a p44/42
MAPK/extracellular-signal regulated kinase (ERK). Eur J Biochem.
268:6058–6065. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chen N, Chen CC and Lau LF: Adhesion of
human skin fibroblasts to Cyr61 is mediated through integrin alpha
6beta 1 and cell surface heparan sulfate proteoglycans. J Biol
Chem. 275:24953–24961. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Grzeszkiewicz TM, Lindner V, Chen N, Lam
SC and Lau LF: The angiogenic factor cysteine-rich 61 (CYR61, CCN1)
supports vascular smooth muscle cell adhesion and stimulates
chemotaxis through integrin alpha(6)beta(1) and cell surface
heparan sulfate proteoglycans. Endocrinology. 143:1441–1450.
2002.PubMed/NCBI
|
|
52
|
Leu SJ, Lam SC and Lau LF: Pro-angiogenic
activities of CYR61 (CCN1) mediated through integrins alphavbeta3
and alpha6beta1 in human umbilical vein endothelial cells. J Biol
Chem. 277:46248–46255. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Babic AM, Chen CC and Lau LF: Fisp12/mouse
connective tissue growth factor mediates endothelial cell adhesion
and migration through integrin alphavbeta3, promotes endothelial
cell survival, and induces angiogenesis in vivo. Mol Cell Biol.
19:2958–2966. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Fukunaga-Kalabis M, Martinez G, Liu ZJ,
Kalabis J, Mrass P, Weninger W, Firth SM, Planque N, Perbal B and
Herlyn M: CCN3 controls 3D spatial localization of melanocytes in
the human skin through DDR1. J Cell Biol. 175:563–569. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Lin CG, Leu SJ, Chen N, Tebeau CM, Lin SX,
Yeung CY and Lau LF: CCN3 (NOV) is a novel angiogenic regulator of
the CCN protein family. J Biol Chem. 278:24200–24208. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Liu H, Dong W, Lin Z, Lu J, Wan H, Zhou Z
and Liu Z: CCN4 regulates vascular smooth muscle cell migration and
proliferation. Mol Cells. 36:112–118. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Jian YC, Wang JJ, Dong S, Hu JW, Hu LJ,
Yang GM, Zheng YX and Xiong WJ: Wnt-induced secreted protein 1/CCN4
in liver fibrosis both in vitro and in vivo. Clin Lab. 60:29–35.
2014.PubMed/NCBI
|
|
58
|
Chowdhury S, Wang X, Srikant CB, Li Q, Fu
M, Gong YJ, Ning G and Liu JL: IGF-I stimulates CCN5/WISP2 gene
expression in pancreatic β-cells, which promotes cell proliferation
and survival against streptozotocin. Endocrinology. 155:1629–1642.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Lake AC and Castellot JJ Jr: CCN5
modulates the antiproliferative effect of heparin and regulates
cell motility in vascular smooth muscle cells. Cell Commun Signal.
1(5)2003. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kleer CG, Zhang Y and Merajver SD: CCN6
(WISP3) as a new regulator of the epithelial phenotype in breast
cancer. Cells Tissues Organs. 185:95–99. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
O'Brien TP and Lau LF: Expression of the
growth factor-inducible immediate early gene cyr61 correlates with
chondrogenesis during mouse embryonic development. Cell Growth
Differ. 3:645–654. 1992.PubMed/NCBI
|
|
62
|
Mo FE, Muntean AG, Chen CC, Stolz DB,
Watkins SC and Lau LF: CYR61 (CCN1) is essential for placental
development and vascular integrity. Mol Cell Biol. 22:8709–8720.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Baguma-Nibasheka M and Kablar B: Pulmonary
hypoplasia in the connective tissue growth factor (Ctgf) null
mouse. Dev Dyn. 237:485–493. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Chiou MJ, Chao TT, Wu JL, Kuo CM and Chen
JY: The physiological role of CTGF/CCN2 in zebrafish notochond
development and biological analysis of the proximal promoter
region. Biochem Biophys Res Commun. 349:750–758. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Heath E, Tahri D, Andermarcher E,
Schofield P, Fleming S and Boulter CA: Abnormal skeletal and
cardiac development, cardiomyopathy, muscle atrophy and cataracts
in mice with a targeted disruption of the Nov (Ccn3) gene. BMC Dev
Biol. 8(18)2008. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
French DM, Kaul RJ, D'Souza AL, Crowley
CW, Bao M, Frantz GD, Filvaroff EH and Desnoyers L: WISP-1 is an
osteoblastic regulator expressed during skeletal development and
fracture repair. Am J Pathol. 165:855–867. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Jones JA, Gray MR, Oliveira BE, Koch M and
Castellot JJ Jr: CCN5 expression in mammals: I. Embryonic and fetal
tissues of mouse and human. J Cell Commun Signal. 1:127–143. 2007.
View Article : Google Scholar
|
|
68
|
Hurvitz JR, Suwairi WM, Van Hul W,
El-Shanti H, Superti-Furga A, Roudier J, Holderbaum D, Pauli RM,
Herd JK, Van Hul EV, et al: Mutations in the CCN gene family member
WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet.
23:94–98. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
69
|
Kutz WE, Gong Y and Warman ML: WISP3, the
gene responsible for the human skeletal disease progressive
pseudorheumatoid dysplasia, is not essential for skeletal function
in mice. Mol Cell Biol. 25:414–421. 2005. View Article : Google Scholar :
|
|
70
|
Hilfiker-Kleiner D, Kaminski K, Kaminska
A, Fuchs M, Klein G, Podewski E, Grote K, Kiian I, Wollert KC,
Hilfiker A, et al: Regulation of proangiogenic factor CCN1 in
cardiac muscle: Impact of ischemia, pressure overload, and
neurohumoral activation. Circulation. 109:2227–2233. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Lau LF and Lam SC: The CCN family of
angiogenic regulators: The integrin connection. Exp Cell Res.
248:44–57. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Grotendorst GR: Connective tissue growth
factor: A mediator of TGF-beta action on fibroblasts. Cytokine
Growth Factor Rev. 8:171–179. 1997. View Article : Google Scholar
|
|
73
|
Ujike K, Shinji T, Hirasaki S, Shiraha H,
Nakamura M, Tsuji T and Koide N: Kinetics of expression of
connective tissue growth factor gene during liver regeneration
after partial hepatectomy and D-galactosamine-induced liver injury
in rats. Biochem Biophys Res Commun. 277:448–454. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Hadjiargyrou M, Ahrens W and Rubin CT:
Temporal expression of the chondrogenic and angiogenic growth
factor CYR61 during fracture repair. J Bone Miner Res.
15:1014–1023. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Xu S-W, Leask A and Abraham D: Regulation
and function of connective tissue growth factor/CCN2 in tissue
repair, scarring and fibrosis. Cytokine Growth Factor Rev.
19:133–144. 2008. View Article : Google Scholar
|
|
76
|
Takehara K: Hypothesis: Pathogenesis of
systemic sclerosis. J Rheumatol. 30:755–759. 2003.PubMed/NCBI
|
|
77
|
Leask A: Targeting the TGFbeta,
endothelin-1 and CCN2 axis to combat fibrosis in scleroderma. Cell
Signal. 20:1409–1414. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Mori T, Kawara S, Shinozaki M, Hayashi N,
Kakinuma T, Igarashi A, Takigawa M, Nakanishi T and Takehara K:
Role and interaction of connective tissue growth factor with
transforming growth factor-beta in persistent fibrosis: A mouse
fibrosis model. J Cell Physiol. 181:153–159. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Lipson KE, Wong C, Teng Y and Spong S:
CTGF is a central mediator of tissue remodeling and fibrosis and
its inhibition can reverse the process of fibrosis. Fibrogenesis
Tissue Repair. 5(Suppl 1): S242012. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Zhang L, Li Y, Liang C and Yang W: CCN5
overexpression inhibits profibrotic phenotypes via the PI3K/Akt
signaling pathway in lung fibroblasts isolated from patients with
idiopathic pulmonary fibrosis and in an in vivo model of lung
fibrosis. Int J Mol Med. 33:478–486. 2014.
|
|
81
|
Wiedmaier N, Müller S, Köberle M, Manncke
B, Krejci J, Autenrieth IB and Bohn E: Bacteria induce CTGF and
CYR61 expression in epithelial cells in a lysophosphatidic acid
receptor- dependent manner. Int J Med Microbiol. 298:231–243. 2008.
View Article : Google Scholar
|
|
82
|
Kim SM, Park JH, Chung SK, Kim JY, Hwang
HY, Chung KC, Jo I, Park SI and Nam JH: Coxsackievirus B3 infection
induces cyr61 activation via JNK to mediate cell death. J Virol.
78:13479–13488. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Muehlich S, Schneider N, Hinkmann F,
Garlichs CD and Goppelt-Struebe M: Induction of connective tissue
growth factor (CTGF) in human endothelial cells by lysophosphatidic
acid, sphingosine-1-phosphate, and platelets. Atherosclerosis.
175:261–268. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Sakamoto S, Yokoyama M, Zhang X, Prakash
K, Nagao K, Hatanaka T, Getzenberg RH and Kakehi Y: Increased
expression of CYR61, an extracellular matrix signaling protein, in
human benign prostatic hyperplasia and its regulation by
lysophosphatidic acid. Endocrinology. 145:2929–2940. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Gery S, Xie D, Yin D, Gabra H, Miller C,
Wang H, Scott D, Yi WS, Popoviciu ML, Said JW, et al: Ovarian
carcinomas: CCN genes are aberrantly expressed and CCN1 promotes
proliferation of these cells. Clin Cancer Res. 11:7243–7254. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Lv H, Fan E, Sun S, Ma X, Zhang X, Han DM
and Cong YS: Cyr61 is up-regulated in prostate cancer and
associated with the p53 gene status. J Cell Biochem. 106:738–744.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Schmitz P, Gerber U, Jüngel E, Schütze N,
Blaheta R and Bendas G: Cyr61/CCN1 affects the integrin-mediated
migration of prostate cancer cells (PC-3) in vitro. Int J Clin
Pharmacol Ther. 51:47–50. 2013. View Article : Google Scholar
|
|
88
|
Goodwin CR, Lal B, Zhou X, Ho S, Xia S,
Taeger A, Murray J and Laterra J: Cyr61 mediates hepatocyte growth
factor-dependent tumor cell growth, migration, and Akt activation.
Cancer Res. 70:2932–2941. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Xie D, Yin D, Tong X, O'Kelly J, Mori A,
Miller C, Black K, Gui D, Said JW and Koeffler HP: Cyr61 is
overexpressed in gliomas and involved in integrin-linked
kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways.
Cancer Res. 64:1987–1996. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Harris LG, Pannell LK, Singh S, Samant RS
and Shevde LA: Increased vascularity and spontaneous metastasis of
breast cancer by hedgehog signaling mediated upregulation of cyr61.
Oncogene. 31:3370–3380. 2012. View Article : Google Scholar :
|
|
91
|
Tsai MS, Hornby AE, Lakins J and Lupu R:
Expression and function of CYR61, an angiogenic factor, in breast
cancer cell lines and tumor biopsies. Cancer Res. 60:5603–5607.
2000.PubMed/NCBI
|
|
92
|
Watari H, Xiong Y, Hassan MK and Sakuragi
N: Cyr61, a member of ccn (connective tissue growth
factor/cysteine-rich 61/nephroblastoma overexpressed) family,
predicts survival of patients with endometrial cancer of
endometrioid subtype. Gynecol Oncol. 112:229–234. 2009. View Article : Google Scholar
|
|
93
|
Monnier Y, Farmer P, Bieler G, Imaizumi N,
Sengstag T, Alghisi GC, Stehle JC, Ciarloni L, Andrejevic-Blant S,
Moeckli R, et al: CYR61 and alphaVbeta5 integrin cooperate to
promote invasion and metastasis of tumors growing in preirradiated
stroma. Cancer Res. 68:7323–7331. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Chen PP, Li WJ, Wang Y, Zhao S, Li DY,
Feng LY, Shi XL, Koeffler HP, Tong XJ and Xie D: Expression of
Cyr61, CTGF, and WISP-1 correlates with clinical features of lung
cancer. PLoS One. 2:e5342007. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Chien W, Kumagai T, Miller CW, Desmond JC,
Frank JM, Said JW and Koeffler HP: Cyr61 suppresses growth of human
endometrial cancer cells. J Biol Chem. 279:53087–53096. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Brigstock DR: The connective tissue growth
factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family.
Endocr Rev. 20:189–206. 1999.PubMed/NCBI
|
|
97
|
Maeta N, Osaki M, Shomori K, Inaba A,
Kidani K, Ikeguchi M and Ito H: CYR61 downregulation correlates
with tumor progression by promoting MMP-7 expression in human
gastric carcinoma. Oncology. 73:118–126. 2007. View Article : Google Scholar
|
|
98
|
Croci S, Landuzzi L, Nicoletti G,
Palladini A, Antognoli A, De Giovanni C, Nanni P and Lollini PL:
Expression of connective tissue growth factor (CTGF/CCN2) in a
mouse model of rhabdomyosarcomagenesis. Pathol Oncol Res.
13:336–339. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Chien W, O'Kelly J, Lu D, Leiter A, Sohn
J, Yin D, Karlan B, Vadgama J, Lyons KM and Koeffler HP: Expression
of connective tissue growth factor (CTGF/CCN2) in breast cancer
cells is associated with increased migration and angiogenesis. Int
J Oncol. 38:1741–1747. 2011.PubMed/NCBI
|
|
100
|
Jiang WG, Watkins G, Fodstad O,
Douglas-Jones A, Mokbel K and Mansel RE: Differential expression of
the CCN family members Cyr61, CTGF and Nov in human breast cancer.
Endocr Relat Cancer. 11:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Jacobson A and Cunningham JL: Connective
tissue growth factor in tumor pathogenesis. Fibrogenesis Tissue
Repair. 5(Suppl 1): S82012. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Lin BR, Chang CC, Chen RJ, Jeng YM, Liang
JT, Lee PH, Chang KJ and Kuo ML: Connective tissue growth factor
acts as a therapeutic agent and predictor for peritoneal
carcinomatosis of colorectal cancer. Clin Cancer Res. 17:3077–3088.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Bennewith KL, Huang X, Ham CM, Graves EE,
Erler JT, Kambham N, Feazell J, Yang GP, Koong A and Giaccia AJ:
The role of tumor cell-derived connective tissue growth factor
(CTGF/CCN2) in pancreatic tumor growth. Cancer Res. 69:775–784.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Shakunaga T, Ozaki T, Ohara N, Asaumi K,
Doi T, Nishida K, Kawai A, Nakanishi T, Takigawa M and Inoue H:
Expression of connective tissue growth factor in cartilaginous
tumors. Cancer. 89:1466–1473. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Chien W, Yin D, Gui D, Mori A, Frank JM,
Said J, Kusuanco D, Marchevsky A, McKenna R and Koeffler HP:
Suppression of cell proliferation and signaling transduction by
connective tissue growth factor in non-small cell lung cancer
cells. Mol Cancer Res. 4:591–598. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Kikuchi R, Tsuda H, Kanai Y, Kasamatsu T,
Sengoku K, Hirohashi S, Inazawa J and Imoto I: Promoter
hypermethylation contributes to frequent inactivation of a putative
conditional tumor suppressor gene connective tissue growth factor
in ovarian cancer. Cancer Res. 67:7095–7105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Li MH, Sanchez T, Pappalardo A, Lynch KR,
Hla T and Ferrer F: Induction of antiproliferative connective
tissue growth factor expression in Wilms' tumor cells by
sphingosine-1-phosphate receptor 2. Mol Cancer Res. 6:1649–1656.
2008.PubMed/NCBI
|
|
108
|
Gardini A, Corti B, Fiorentino M, Altimari
A, Ercolani G, Grazi GL, Pinna AD, Grigioni WF and D'Errico
Grigioni A: Expression of connective tissue growth factor is a
prognostic marker for patients with intrahepatic
cholangiocarcinoma. Dig Liver Dis. 37:269–274. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Lin BR, Chang CC, Che TF, Chen ST, Chen
RJ, Yang CY, Jeng YM, Liang JT, Lee PH, Chang KJ, et al: Connective
tissue growth factor inhibits metastasis and acts as an independent
prognostic marker in colorectal cancer. Gastroenterology. 128:9–23.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Maillard M, Cadot B, Ball RY, Sethia K,
Edwards DR, Perbal B and Tatoud R: Differential expression of the
ccn3 (nov) proto-oncogene in human prostate cell lines and tissues.
Mol Pathol. 54:275–280. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Manara MC, Perbal B, Benini S, Strammiello
R, Cerisano V, Perdichizzi S, Serra M, Astolfi A, Bertoni F, Alami
J, et al: The expression of ccn3(nov) gene in musculoskeletal
tumors. Am J Pathol. 160:849–859. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Gluk hova L, Angevin E, Lavialle C, Cadot
B, Terrier-Lacombe MJ, Perbal B, Bernheim A and Goguel AF: Patterns
of specific genomic alterations associated with poor prognosis in
high-grade renal cell carcinomas. Cancer Genet Cytogenet.
130:105–110. 2001. View Article : Google Scholar
|
|
113
|
Perbal B: CCN3: Doctor Jekyll and Mister
Hyde. J Cell Commun Signal. 2:3–7. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Zhang T, Zhao C, Luo L, Xiang J, Sun Q,
Cheng J and Chen D: The clinical and prognostic significance of
CCN3 expression in patients with cervical cancer. Adv Clin Exp Med.
22:839–845. 2013.
|
|
115
|
Gupta N, Wang H, McLeod TL, Naus CC,
Kyurkchiev S, Advani S, Yu J, Perbal B and Weichselbaum RR:
Inhibition of glioma cell growth and tumorigenic potential by CCN3
(NOV). Mol Pathol. 54:293–299. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Bleau AM, Planque N, Lazar N, Zambelli D,
Ori A, Quan T, Fisher G, Scotlandi K and Perbal B:
Antiproliferative activity of CCN3: Involvement of the C-terminal
module and post-translational regulation. J Cell Biochem.
101:1475–1491. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
McCallum L, Lu W, Price S, Lazar N, Perbal
B and Irvine AE: CCN3 suppresses mitogenic signalling and
reinstates growth control mechanisms in chronic myeloid leukaemia.
J Cell Commun Signal. 6:27–35. 2012. View Article : Google Scholar :
|
|
118
|
Thibout H, Martinerie C, Créminon C,
Godeau F, Boudou P, Le Bouc Y and Laurent M: Characterization of
human NOV in biological fluids: An enzyme immunoassay for the
quantification of human NOV in sera from patients with diseases of
the adrenal gland and of the nervous system. J Clin Endocrinol
Metab. 88:327–336. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Xin LW, Martinerie C, Zumkeller W,
Westphal M and Perbal B: Differential expression of novH and CTGF
in human glioma cell lines. Clin Mol Pathol. 49:M91–M97. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Sin WC, Bechberger JF, Rushlow WJ and Naus
CC: Dose-dependent differential upregulation of CCN1/Cyr61 and
CCN3/NOV by the gap junction protein Connexin43 in glioma cells. J
Cell Biochem. 103:1772–1782. 2008. View Article : Google Scholar
|
|
121
|
Fukunaga-Kalabis M, Martinez G, Telson SM,
Liu ZJ, Balint K, Juhasz I, Elder DE, Perbal B and Herlyn M:
Downregulation of CCN3 expression as a potential mechanism for
melanoma progression. Oncogene. 27:2552–2560. 2008. View Article : Google Scholar
|
|
122
|
Chuang JY, Chang AC, Chiang IP, Tsai MH
and Tang CH: Apoptosis signal-regulating kinase 1 is involved in
WISP-1-promoted cell motility in human oral squamous cell carcinoma
cells. PLoS One. 8:e780222013. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Hashimoto Y, Shindo-Okada N, Tani M,
Takeuchi K, Toma H and Yokota J: Identification of genes
differentially expressed in association with metastatic potential
of K-1735 murine melanoma by messenger RNA differential display.
Cancer Res. 56:5266–5271. 1996.PubMed/NCBI
|
|
124
|
Hashimoto Y, Shindo-Okada N, Tani M,
Nagamachi Y, Takeuchi K, Shiroishi T, Toma H and Yokota J:
Expression of the Elm1 gene, a novel gene of the CCN (connective
tissue growth factor, Cyr61/Cef10, and neuroblastoma overexpressed
gene) family, suppresses in vivo tumor growth and metastasis of
K-1735 murine melanoma cells. J Exp Med. 187:289–296. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Soon LL, Yie TA, Shvarts A, Levine AJ, Su
F and Tchou-Wong KM: Overexpression of WISP-1 down-regulated
motility and invasion of lung cancer cells through inhibition of
Rac activation. J Biol Chem. 278:11465–11470. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Yu C, Le AT, Yeger H, Perbal B and Alman
BA: NOV (CCN3) regulation in the growth plate and CCN family member
expression in cartilage neoplasia. J Pathol. 201:609–615. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Davies SR, Watkins G, Mansel RE and Jiang
WG: Differential expression and prognostic implications of the CCN
family members WISP-1, WISP-2, and WISP-3 in human breast cancer.
Ann Surg Oncol. 14:1909–1918. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Tomimaru Y, Koga H, Yano H, de la Monte S,
Wands JR and Kim M: Upregulation of T-cell factor-4
isoform-responsive target genes in hepatocellular carcinoma. Liver
Int. 33:1100–1112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Colli LM, Saggioro F, Serafini LN, Camargo
RC, Machado HR, Moreira AC, Antonini SR and de Castro M: Components
of the canonical and non-canonical Wnt pathways are not
mis-expressed in pituitary tumors. PLoS One. 8:e624242013.
View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Ji J, Jia S, Ji K and Jiang WG: Wnt1
inducible signalling pathway protein-2 (WISP 2/CCN5): Roles and
regulation in human cancers (Review). Oncol Rep. 31:533–539.
2014.
|
|
131
|
Banerjee S, Dhar G, Haque I, Kambhampati
S, Mehta S, Sengupta K, Tawfik O, Phillips TA and Banerjee SK:
CCN5/WISP-2 expression in breast adenocarcinoma is associated with
less frequent progression of the disease and suppresses the
invasive phenotypes of tumor cells. Cancer Res. 68:7606–7612. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Dhar K, Banerjee S, Dhar G, Sengupta K and
Banerjee SK: Insulin-like growth factor-1 (IGF-1) induces
WISP-2/CCN5 via multiple molecular cross-talks and is essential for
mitogenic switch by IGF-1 axis in estrogen receptor-positive breast
tumor cells. Cancer Res. 67:1520–1526. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Banerjee SK and Banerjee S: CCN5/WISP-2: A
micromanager of breast cancer progression. J Cell Commun Signal.
6:63–71. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Yang Z, Yang Z, Zou Q, Yuan Y, Li J, Li D,
Liang L, Zeng G and Chen S: A comparative study of
clinicopathological significance, FGFBP1, and WISP-2 expression
between squamous cell/adenosquamous carcinomas and adenocarcinoma
of the gallbladder. Int J Clin Oncol. 19:325–335. 2014. View Article : Google Scholar
|
|
135
|
Dhar G, Mehta S, Banerjee S, Gardner A,
McCarty BM, Mathur SC, Campbell DR, Kambhampati S and Banerjee SK:
Loss of WISP-2/CCN5 signaling in human pancreatic cancer: A
potential mechanism for epithelial-mesenchymal-transition. Cancer
Lett. 254:63–70. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Kouzu Y, Uzawa K, Kato M, Higo M, Nimura
Y, Harada K, Numata T, Seki N, Sato M and Tanzawa H: WISP-2
expression in human salivary gland tumors. Int J Mol Med.
17:567–573. 2006.PubMed/NCBI
|
|
137
|
Thorstensen L, Diep CB, Meling GI, Aagesen
TH, Ahrens CH, Rognum TO and Lothe RA: WNT1 inducible signaling
pathway protein 3, WISP-3, a novel target gene in colorectal
carcinomas with microsatellite instability. Gastroenterology.
121:1275–1280. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Cervello M, Giannitrapani L, Labbozzetta
M, Notarbartolo M, D'Alessandro N, Lampiasi N, Azzolina A and
Montalto G: Expression of WISPs and of their novel alternative
variants in human hepatocellular carcinoma cells. Ann NY Acad Sci.
1028:432–439. 2004. View Article : Google Scholar
|
|
139
|
Fang F, Zhao WY, Li RK, Yang XM, Li J, Ao
JP, Jiang SH, Kong FZ, Tu L, Zhuang C, et al: Silencing of WISP3
suppresses gastric cancer cell proliferation and metastasis and
inhibits Wnt/β-catenin signaling. Int J Clin Exp Pathol.
7:6447–6461. 2014.
|
|
140
|
Huang W, Zhang Y, Varambally S, Chinnaiyan
AM, Banerjee M, Merajver SD and Kleer CG: Inhibition of CCN6
(Wnt-1-induced signaling protein 3) down-regulates E-cadherin in
the breast epithelium through induction of snail and ZEB1. Am J
Pathol. 172:893–904. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
van Golen KL, Davies S, Wu ZF, Wang Y,
Bucana CD, Root H, Chandrasekharappa S, Strawderman M, Ethier SP
and Merajver SD: A novel putative low-affinity insulin-like growth
factor-binding protein, LIBC (lost in inflammatory breast cancer),
and RhoC GTPase correlate with the inflammatory breast cancer
phenotype. Clin Cancer Res. 5:2511–2519. 1999.PubMed/NCBI
|
